- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1CY: 1-(4-chlorophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 28 residues within 4Å:- Chain A: C.15, V.16, L.40, G.41, N.42, G.44, V.45, L.46, G.105, R.106, T.107, T.108, L.127, S.128, R.129, T.130, N.144, K.145, V.146, I.164, G.165, G.166, S.167, V.168, V.169, Y.170, E.172
- Ligands: 1CY.1
34 PLIP interactions:34 interactions with chain A- Hydrophobic interactions: A:T.108, A:Y.170
- Hydrogen bonds: A:V.16, A:L.40, A:N.42, A:G.44, A:G.105, A:G.105, A:R.106, A:T.107, A:T.107, A:T.108, A:S.128, A:R.129, A:T.130, A:T.130, A:G.166, A:S.167, A:V.168, A:V.169, A:E.172
- Water bridges: A:G.41, A:G.44, A:R.129, A:R.129, A:R.129, A:R.129, A:R.129, A:R.129, A:R.129, A:R.129, A:V.146
- Salt bridges: A:R.106
- pi-Cation interactions: A:R.129
NDP.5: 28 residues within 4Å:- Chain B: C.15, V.16, L.40, G.41, N.42, G.44, V.45, L.46, G.105, R.106, T.107, T.108, L.127, S.128, R.129, T.130, N.144, V.146, I.164, G.165, G.166, S.167, V.168, V.169, Y.170, E.172, V.195
- Ligands: 1CY.4
24 PLIP interactions:24 interactions with chain B- Hydrophobic interactions: B:T.108, B:Y.170
- Hydrogen bonds: B:V.16, B:L.40, B:N.42, B:G.44, B:G.44, B:G.105, B:G.105, B:R.106, B:T.107, B:T.107, B:T.108, B:T.108, B:S.128, B:R.129, B:T.130, B:G.166, B:S.167, B:V.168, B:V.169, B:Y.170, B:E.172
- Salt bridges: B:R.106
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
UMP.3: 15 residues within 4Å:- Chain A: R.345, C.490, H.491, Q.509, R.510, S.511, C.512, D.513, G.517, V.518, N.521, H.551, Y.553
- Chain B: R.470, R.471
13 PLIP interactions:11 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:D.513
- Hydrogen bonds: A:Q.509, A:S.511, A:S.511, A:D.513, A:V.518, A:N.521, A:N.521, A:H.551
- Salt bridges: A:R.345, A:R.510, B:R.470, B:R.471
UMP.6: 15 residues within 4Å:- Chain A: R.470, R.471
- Chain B: R.345, C.490, H.491, Q.509, R.510, S.511, C.512, D.513, G.517, V.518, N.521, H.551, Y.553
12 PLIP interactions:10 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:Q.509, B:S.511, B:D.513, B:V.518, B:N.521, B:N.521, B:H.551, B:Y.553
- Salt bridges: B:R.345, B:R.510, A:R.470, A:R.471
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vanichtanankul, J. et al., Combined Spatial Limitation around Residues 16 and 108 of Plasmodium falciparum Dihydrofolate Reductase Explains Resistance to Cycloguanil. Antimicrob.Agents Chemother. (2012)
- Release Date
- 2012-07-18
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1CY: 1-(4-chlorophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vanichtanankul, J. et al., Combined Spatial Limitation around Residues 16 and 108 of Plasmodium falciparum Dihydrofolate Reductase Explains Resistance to Cycloguanil. Antimicrob.Agents Chemother. (2012)
- Release Date
- 2012-07-18
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B